Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer.
Spring LM, Clark SL, Li T, Goel S, Tayob N, Viscosi E, Abraham E, Juric D, Isakoff SJ, Mayer E, Moy B, Supko JG, Tolaney SM, Bardia A.
Spring LM, et al. Among authors: viscosi e.
NPJ Breast Cancer. 2021 Aug 4;7(1):103. doi: 10.1038/s41523-021-00311-y.
NPJ Breast Cancer. 2021.
PMID: 34349115
Free PMC article.